GLP-1 ID Individualized Dosing
Individualized Weight Loss
Your Body. Your Results.
Weekly provider check-ins. Adjustments based on your progress. Care that evolves with you.
What is Individualized Care?
With GLP-1 ID, your care isn't just personalized— it's fully individualized, reflecting your body's rhythm, your lifestyle, and your goals, one week at a time.
Ivím's individualized care: Based on you. Competitors: Basic personalized care — based on general patterns.
| Ivím | Other Competitors | |
|---|---|---|
| Individualized GLP-1 care model | ✓ | — |
| Unlimited provider access | ✓ | — |
| Weekly dose adjustments | ✓ | — |
| 1:1 Virtual Holistic Consultations ($850 value) | ✓ | — |
| Master classes, group coaching & community ($500 value) | ✓ | Limited |
| 20% off physician formulated supplements | ✓ | — |
| Easy progress tracking with the Ivím Health App | ✓ | Limited |
Traditional medicine: individualized GLP-1 care model in-clinic only.
Individualized Care, Made Affordable
Program Fee
*Programs available in 1, 2, 4, or 6-month durations
See your weight loss Potential
Based on Ivim's published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks. Not a head-to-head study. RX required after clinical evaluation. This is a compounded medication and is not FDA-approved. Compounded drugs have not undergone FDA review for safety, efficacy, or quality.
Board Certified Providers
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Ivím provider
Founded for Better Care
Ivím Health was founded in 2021 by Dr. Taylor Kantor, alongside his brother Anthony and Anthony's wife, Kelly, to reimagine care for cardiometabolic conditions—making it more accessible, individualized, and data-driven.
Blending medical precision with a holistic mindset, they set out to build a modern model of care that puts the individual first.
Understanding individualized compounded GLP-1 medications
What makes GLP-1 ID different?
GLP-1 ID combines customized care, flexible medication options, and ongoing support to deliver better results than one-size-fits-all approaches.
Are GLP-1 medications safe?
Yes, when prescribed by a licensed provider and monitored appropriately.
What are the most common side effects of compounded GLP-1 medications?
The most common side effects of compounded semaglutide and compounded tirzepatide are similar to their brand-name counterparts and are typically gastrointestinal in nature, including:
Nausea
Vomiting
Diarrhea
Constipation
Bloating or gas
Decreased appetite or early satiety
These side effects are usually mild to moderate and tend to improve over time, especially with gradual dose escalation under provider supervision.
What if I prefer branded medications?
You still have full access to Zepbound® and Wegovy® if you choose through our traditional GLP-1 program.
How do I know if I'm eligible?
Our intake questionnaire and consultation with a provider determine if you medically qualify.
Can I cancel anytime?
Our GLP-1 ID programs are structured based on the duration you select at checkout. Most patients begin with the Jumpstart option, which is a 4-month commitment.
You can choose from 1, 2, 4, or 6-month programs, and your access to care, medication, and support will remain active for the full duration you select.
Because GLP-1 medications are prescribed and shipped based on your selected program length, cancellation is not available once your program has started.
(All compounded medication purchases are considered part of the GLP-1 ID program.)
Your body. Your results.
*Based on Ivim's published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks. Not a head-to-head study. RX required after clinical evaluation. This is a compounded medication and is not FDA-approved. Compounded drugs have not undergone FDA review for safety, efficacy, or quality. See Ivím website for full safety information. Results may vary.
*Based on our internal data and individual patient outcomes may vary. This does not constitute a guarantee of specific results.
✝ These results include data from patients using both FDA-approved and compounded formulations.